Overall, the evidence points to GLP-1 receptor agonists as promising adjunctive treatments that can reduce binge eating symptoms and improve related eating behaviors in people living with obesity
About one in nine Americans take a GLP-1 medication for weight loss, results from a new Gallup poll founda staggering rise over the past two years as the obesity rate in the U.S
Additionally, drugs like metformin and simvastatin, which can penetrate the blood-brain barrier and alter metabolic pathways, have shown great feasibility in the treatment of gliomas
These include the ventral and dorsal striatum, anterior cingulate, orbitofrontal cortex, and amygdala, which typically exhibit greater activation to food or alcohol stimuli in people with obesity or AUD compared to controls [164, 173, 175, 178]
This work was supported by the National Institutes of Health (R01 GM065383 to DS) and the National Aeronautics and Space Administration (80NSSC23K0302 to DS)
If youre concerned about affordability, consider these practical steps: Review Your Insurance Plan Carefully Confirm whether your plan covers GLP-1 medications for diabetes, weight loss, or both
